Concepedia

Yan-Ran Bi

YB

Statistics

Publications

4

Citations

146

H-Index

4

Active since

2019

Affiliations

China Pharmaceutical University(Current)

Chonnam National University

Yan-Ran Bi is an author at China Pharmaceutical University specializing in pharmacology, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2023

4

Publications

4

A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours

Rong Fu, Chenfeng Han, Ting Ni et al. · Nature Communications · 2019 · 63 citations · Full text

A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer

Hongmei Li, Yan-Ran Bi, Li Yang et al. · Science Advances · 2020 · 51 citations · Full text

, , +14

A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis

Yan-Ran Bi, Ruiling Zheng, Jiahao Hu et al. · Genes & Diseases · 2023 · 17 citations · Full text

The Effects of Triterpenoid Saponins from the Seeds of Momordica cochinchinensis on Adipocyte Differentiation and Mature Adipocyte Inflammation

Jae Sik Yu, Namood-e Sahar, Yan-Ran Bi et al. · Plants · 2020 · 15 citations · Full text

1–4 of 4